Quick Answer
Profound Medical Corp. reported Stockholders Equity of $66.43 million for fiscal year 2025.
Profound Medical Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $66.43M | +10.0% |
| 2024 | $60.42M | +93.5% |
| 2023 | $31.22M | -40.6% |
| 2022 | $52.60M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.14M | +4.6% | -18.1% |
| June 30, 2025 | $39.26M | +0.9% | -22.7% |
| March 31, 2025 | $50.79M | +11.6% | -15.9% |
| December 31, 2024 | $60.42M | +93.5% | +96.7% |
| September 30, 2024 | $30.72M | — | -21.0% |
| June 30, 2024 | $38.90M | — | -14.5% |
| March 31, 2024 | $45.52M | — | +45.8% |
| December 31, 2023 | $31.22M | — | — |
- Profound Medical Corp. showed an increase of +10.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Profound Medical Corp.’s stockholders equity has grown by 26.3% (from $52.60 million to $66.43 million).
- The most recent figure is from Profound Medical Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: